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Purpose: Perioperative dextrose-containing fluid administration has been used as a 
non-pharmacologic preventive measure against postoperative nausea and vomiting (PONV), a 
common and distressing complication of anesthesia. However, its efficacy remains unclear as 
previous studies reported inconsistent results. Our objective was to compare dextrose-containing 
fluid with non-dextrose-containing fluid in terms of PONV for 24 hours after surgery under 
general anesthesia. The effects of dextrose according to different types of surgery and the fluid 
volume were also examined.
Methods: We performed a systematic review and meta-analysis of randomized controlled trials 
(RCTs) comparing dextrose-containing fluid with non-dextrose-containing fluids after general 
anesthesia in terms of PONV incidence and the need for rescue anti-emetic therapies for 24 hours 
after surgery. A literature search was performed, using Medline, EMBASE, Cochrane Central 
Register of Controlled Trials, Web of Science, and Scopus, up to February 2018.
Results: We included seven RCTs. Compared with the control group, perioperative dextrose 
administration did not reduce the risk for PONV, with a relative risk (RR) of 0.72 (95% CI: 
0.50–1.03). However, perioperative dextrose reduced the requirement for anti-emetics, compared 
with the control group, with a RR of 0.60 (95% CI: 0.44–0.83). The quality of evidence in this 
meta-analysis was poor due to high risks of selection and performance biases and substantial 
statistical heterogeneity. After subgroup analysis, the risk for PONV was reduced in patients 
who had undergone laparoscopic cholecystectomy, but not other surgeries, and the effects of 
dextrose on the risk for PONV did not differ according to the fluid volume administered.
Conclusion: Perioperative intravenous (i.v.) dextrose did not reduce the risk for PONV. How-
ever, it did reduce the need for anti-emetics after general anesthesia. Furthermore, the effects 
of dextrose varied according to the surgery type. Further studies are needed to determine the 
benefits of perioperative i.v. dextrose administration as a preventive measure against PONV.
Keywords: general anesthesia, PONV, dextrose, laparoscopic cholecystectomy
Introduction
Postoperative nausea and vomiting (PONV) is a common and distressing complica-
tion of surgery and anesthesia. Although these symptoms are usually self-limiting 
and non-fatal, they may cause problems, such as aspiration pneumonia, dehydration, 
prolonged hospitalization, wound dehiscence, water and electrolyte disturbances, and 
acid-base imbalances.1 From the patient’s perspective, the experience of PONV may be 
worse than postoperative pain.2 Currently, many anti-emetic medications are used to 
prevent PONV. However, these relatively expensive drugs are associated with adverse 
effects, such as oversedation, hypotension, dry mouth, and dysphoria.3 Although 
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non-pharmacological approaches, such as oral carbohydrate4,5 
or fluid therapy have been attempted to minimize the cost 
and the potential side effects of the anti-emetics, there is 
limited evidence regarding adjuvant non-pharmacological 
therapies for PONV.
Gastric mucosal hypoperfusion consequent to hypov-
olemia, which can occur after prolonged fasting, may also be 
an important etiological factor for PONV.6 Intravenous (i.v.) 
fluid administration is known to reduce hypovolemia and 
hypoperfusion. Accordingly, many studies have evaluated 
whether the i.v. administration of dextrose-containing fluid 
can effectively prevent PONV via a mechanism potentially 
involving hyperglycemia.7,8 However, the ability of such 
fluid to prevent PONV remains controversial. Therefore, 
with this meta-analysis, we aimed to compare the effica-
cies of dextrose-containing fluid with other fluid for the 
prevention of PONV in multiple randomized controlled 
trials (RCTs).
Methods
Using multiple comprehensive databases, we sought litera-
ture comparing the effects of dextrose-containing fluid with 
non-dextrose-containing fluid on the incidence of PONV. 
This study was conducted according to the Cochrane Review 
Methods,9 and the PRISMA reporting guidelines.
Data and literature sources
We searched the Medline, EMBASE, Cochrane Central 
Register of Controlled Trials, Web of Science, and Scopus 
databases in February 2018. Initially, we used the following 
keywords and MeSH terms to search Medline: Postoperative 
Nausea and Vomiting, Glucose, Sodium Lactate, Anesthesia. 
Subsequently, these search strategies were adapted for 
other databases. No restrictions on publication language 
or year were applied. After the initial electronic search, we 
hand-searched further relevant articles from the identified 
studies. All identified articles were individually assessed 
for inclusion.
study selection
Two reviewers (SHK and HJK) independently determined the 
inclusion of all studies according to the selection criteria. Two 
levels of screening were applied to the identified studies. At 
the first level, the titles and abstracts of the identified studies 
were screened. At the second level, the full text was reviewed. 
Studies were included in our meta-analysis if they met the 
following inclusion criteria: 1) a study population comprising 
adult patients undergoing surgery under general anesthesia; 
2) an intervention of dextrose-containing fluid and control of 
fluid without dextrose; 3) outcome measures, including the 
incidence of PONV and need for rescue anti-emetic therapies; 
and 4) a prospective RCT design. Duplicate publications, 
review articles, and case reports were excluded.
Data extraction
The two reviewers (SHK and HJK) independently extracted 
data from each study using a predefined data extraction form. 
Any disagreement unresolved by discussion was submitted 
for review by a third author (YSC). The variables extracted 
were as follows: first author, publication year, baseline 
characteristics of patients, type of surgery, fluid interven-
tion, and outcome results, including the incidence of PONV, 
incidence of vomiting, and number of patients requiring 
rescue anti-emetics.
assessment of methodological quality
Two reviewers (SHK and HJK) independently assessed the 
methodological quality of each study using the Cochrane 
Collaboration tool for assessing the risk of bias. We assessed 
the following domains: random sequence generation, allo-
cation concealment, blinding of participants and personnel, 
blinding of outcome assessment, incomplete outcome data, 
and selective reporting.
Publication bias was not assessable in these trials, as the 
tests for funnel plot asymmetry are generally only performed 
for a meta-analysis of at least 10 studies. Because our analysis 
included only seven studies, tests for asymmetry would be 
unable to differentiate chance from asymmetry and would 
thus be ineffective.
gRaDe assessment and summary of 
findings
We used the Grading of Recommendations Assessment, 
Development, and Evaluation (GRADE) approach to 
assess the quality of the evidence associated with specific 
outcomes (incidence of PONV, postoperative vomiting, and 
requirement for anti-emetics) in our review and to construct 
a “summary of findings” table. The GRADE approach 
considers study risk of bias (methodological quality), direct-
ness of the evidence, heterogeneity of the data, precision of 
effect estimates, and risk of publication bias.
statistical analysis
The primary outcome of our meta-analysis was the risk 
for PONV for 24 hours after surgery, while the secondary 
outcomes were the risk for postoperative vomiting and 
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requirement for anti-emetic therapy for 24 hours after 
surgery. For dichotomous outcomes (incidences of PONV, 
postoperative vomiting, and anti-emetic requirements), the 
results are expressed as relative risks (RRs) with 95% CIs. 
Data were pooled using a random-effects model, and the 
mean differences and 95% CI are reported if continuous 
scales of measurement were used to assess the effects of 
treatment (postoperative glucose levels).
To estimate heterogeneity, we determined the proportion 
of between-study inconsistency attributable to true differ-
ences between studies (rather than differences attributable 
to random error or chance) using the I2 statistic, wherein 
values of 25%, 50%, and 75% are considered low, moder-
ate, and high, respectively. Here, we conducted subgroup 
analyses of situations where type of heterogeneity might 
affect the results (type of surgery and volume of dextrose 
fluid). Three studies included patients undergoing laparo-
scopic cholecystectomy, three included patients undergoing 
gynecologic surgery, and one included patients undergoing 
gynecologic, urologic, or breast surgery. Accordingly, the 
type of surgery subgroups comprised laparoscopic chole-
cystectomy and gynecologic, urologic, or breast surgery. 
As all studies used 5% glucose in the dextrose group, three 
subgroups were classified according to dextrose fluid vol-
umes of .1,000 mL, 500–1,000, and ,500 mL. All analy-
ses were performed using RevMan version 5.2 (Cochrane 
Community, London, UK).
Results
Identification of studies
Our database searches yielded 8,138 articles. Of these, 583 
publications were excluded as duplicates, and 7,477 were 
excluded because the title and abstract indicated that the 
studies did not fulfill the selection criteria. We obtained full 
manuscripts of the remaining 78 articles and, after a close 
review, identified seven relevant studies. Ultimately, seven 
studies10–16 were included in the review (Figure 1).
study characteristics and patient 
populations
The seven studies had enrolled a total of 701 patients who 
underwent surgery under general anesthesia (Table 1). Of 
these, 347 patients had been assigned randomly to control 
groups; the remaining 354 patients had been assigned to 
dextrose intervention groups. The incidence of PONV was 
the primary outcome in six studies. Five studies included only 
female patients, while two included both male and female 
patients. Of the 49 male patients included in the analysis, 
27 and 22 were included in the control and dextrose groups, 
respectively.
As noted previously, all patients in the dextrose group 
were administered a 5% dextrose solution; patients in the 
control group were administered identical amounts of fluid 
without dextrose. In four studies, patients were administered 
250–1,000 mL of fluid. In the remaining three studies, the 
amount of fluid was determined taking into consideration 
the body weight and duration of surgery. The timing of the 
intervention varied among the studies. The intervention was 
performed intraoperatively in three studies,10,13,14 postopera-
tively in three studies,11,15,16 and preoperatively in one study.12 
Two studies each were performed in India, Iran, and the USA, 
while one study was performed in Ireland.
Quality of the included studies
The Cochrane Collaboration’s risk of bias tool was used 
to assess the risk of bias in all included studies. The items 
assessed and recorded were as follows: random sequence 
generation (selection bias), allocation concealment (selec-
tion bias), blinding of participants and personnel (perfor-
mance bias), blinding of outcome assessment (detection 
bias), incomplete outcome data (attrition bias), and selec-
tive reporting (reporting bias). The risks of biases were 
Figure 1 Meta-analysis flow chart.
Abbreviation: RCT, randomized controlled trial.
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substantial (Figure 2). Three studies were considered high 
risk for allocation and four were considered high risk for the 
blinding of participants. However, these risks were unlikely 
to lead to further intervention during anesthesia or to have 
influenced the outcome assessment. The overall quality 
of the studies was found to be moderate to low using the 
GRADE approach. 
incidence of POnV and requirement for 
anti-emetics
Six studies10,11,13–16 reported the incidence of PONV. The 
results of our meta-analysis indicated that perioperative 
dextrose administration did not reduce the risk for PONV, 
compared with the control group (RR: 0.72, 95% CI: 
0.50–1.03) (Figure 3), and there was evidence of substantial 
heterogeneity (I2=71%). Two other studies15,16 also found that 
dextrose did not reduce the risk for vomiting (RR: 0.79, 95% 
CI: 0.39–1.61) (Figure 4). However, perioperative dextrose 
reduced the requirement for anti-emetics, compared with the 
control group (RR: 0.60, 95% CI: 0.44–0.83) (Figure 5). As 
with PONV, there was evidence of heterogeneity (I2=54%, 
moderate). The outcome of PONV was not affected by the 
inclusion of only high-quality studies11,14,15 (RR: 0.71, 95% 
CI: 0.40–1.23) or the exclusion of two studies11,16 interven-
tion of which was performed at postanesthesia care unit 
(RR: 0.76, 95% CI: 0.42–1.39).
A subgroup analysis stratified by type of surgery demon-
strated that perioperative dextrose could effectively prevent 
PONV associated with laparoscopic cholecystectomy. A total 
of 336 patients were included in three studies of laparoscopic 
cholecystectomy.12,14,16 The results of two studies14,16 showed 
that dextrose significantly reduced the risk for PONV relative 
to the control group (Figure 3). All three studies reported the 
requirement for anti-emetics, which was also reduced in the 
dextrose group relative to the control group (Figure 5).
Table 1 The main characteristics of the studies included in the meta-analysis
Number 
(control, 
dextrose)
Incidence of 
PONV (control, 
dextrose)
Population (ASA, 
sex, age [control], 
age [dextrose])
Type of 
surgery
Control fluid Dextrose fluid Timing of 
intervention
atashkhoei 
et al10
70  
(35, 35)
16/35, 8/35 1, female,
32.09 (±1.02)
30.49 (±0.91)
Diagnostic 
laparoscopy for 
infertility
Ringer’s lactate
714.7 ml
(10 ml kg-1 h-1)
5% dextrose in 
Ringer’s lactate
608.1 ml
(10 ml kg-1 h-1)
intraoperatively
Dabu-
Bondoc 
et al11
62  
(32, 30)
20/32, 14/30 1–2, female,
37.5 (±9.8)
37.9 (±10.3)
gynecologic, 
laparoscopic and 
hysteroscopic 
procedures
Ringer’s lactate
1,000 ml
5% dextrose in 
Ringer’s lactate
1,000 ml
immediately 
after surgery 
(in the PaCU), 
.30 minutes
Firouzian 
et al12
121 
(60, 61)
na 1–2, female, 
41.44 (±12.75)
41.2 (±12.73)
laparoscopic 
cholecystectomy
Ringer’s lactate
500 ml
5% dextrose in 
Ringer’s lactate
500 ml
30 minutes before 
induction of 
anesthesia,
.30 minutes
McCaul 
et al13
71  
(36, 35)
6/36, 10/35 1, female,
32.3 (±4.96)
33.2 (±4.9)
elective 
gynecological 
laparoscopy
Ringer’s lactate
1,115 (±363) ml
(1.5 ml kg-1 h-1 
of fasting)
5% dextrose in 
Ringer’s lactate
1,148 (±210) ml
(1.5 ml kg-1 h-1 
of fasting)
after induction of 
anesthesia,
.20 minutes
Mishra 
et al14
100 
(50, 50)
33/50, 14/50 1–2, female and 
male,
39.6 (±11.54)
37.42 (±12.00)
laparoscopic 
cholecystectomy
0.9% saline
250 ml
5% dextrose
,108 ml
(100 ml h-1)
initiation upon 
gallbladder removal, 
continued until 
surgery completion
Patel et al15 162 
(75, 87)
38/75, 47/87 1–2, female,
45.5 (43.0–47.9)
46.3 (43.7–48.9)
gynecologic, 
urologic or 
breast surgery
Ringer’s lactate
250 ml
5% dextrose in 
Ringer’s lactate
250 ml
initiated with 
surgical closure,
.2 hours
Rao et al16 115 
(59, 56)
43/59, 24/56 1–2, female and 
male,
43 (±13)
44 (±11)
laparoscopic 
cholecystectomy
Ringer’s lactate
1,000 ml
5% dextrose
1,000 ml
after the end of 
surgery in the 
PaCU, .30 minutes
Note: ages are presented as mean (±sD), or mean (95% Ci).
Abbreviations: ASA, American Society of Anesthesiologists physical status classification; NA, not applicable; PACU, postanesthesia care unit; PONV, postoperative nausea 
and vomiting.
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In contrast, perioperative dextrose did not improve the 
risk for PONV in studies of gynecologic, urologic, and/or 
breast surgery.10,11,13,15 A total of 365 patients were included 
in four such studies. Most underwent gynecologic surgery, 
while 20 patients in the dextrose group and 18 in the control 
group underwent urologic or breast surgery. In all four stud-
ies, dextrose did not reduce the risk for PONV relative to the 
control group (Figure 3). Similarly, three studies10,11,15 found 
no difference in the requirement for anti-emetics between the 
dextrose and control groups (Figure 5).
A subgroup analysis stratified by the volume of dextrose 
fluid demonstrated that the i.v. administration of .1,000 mL 
reduced the risk for PONV. However, there was no sig-
nificant difference between the dextrose fluid-volume 
subgroups (I2=0%) (Figure 6). Four studies10,12,15,16 reported 
the postoperative glucose levels (mg dL-1). In all but one 
heterogeneous study, the postoperative glucose levels were 
higher in the dextrose group relative to the control group 
(weighted mean difference =20.83, 95% CI: 3.77–37.88) 
(Figure 7).
Discussion
In this meta-analysis, we found that the perioperative 
administration of dextrose did not seem to reduce the risk 
for PONV among patients undergoing surgery under gen-
eral anesthesia. However, the results of this review should 
be considered cautiously. We do not condemn the general 
use of perioperative dextrose, as the analysis indicated a 
decrease in the requirement for anti-emetics in the dextrose 
group; rather, we find no evidence to support the routine use 
of perioperative dextrose as a prophylaxis against PONV in 
patients placed under general anesthesia. We particularly 
note that although most studies were heterogeneous, McCaul 
et al13 reported that the incidence of PONV was higher in 
the dextrose group than in the control group. Patients in that 
study received anesthesia for a duration of ,25 minutes, 
which was shorter than in other studies, as well as a rela-
tively large volume of dextrose. The duration of anesthesia 
has been identified as an independent risk factor for PONV 
development,17 and the administration of large amounts of 
dextrose during a short surgery with an otherwise low risk 
of PONV might only increase gastric emptying and gastric 
fullness consequent to hyperglycemia. It is well known that 
acute hyperglycemia slows gastric emptying both in healthy 
subjects and patients with diabetes mellitus.18–20
General anesthesia with volatile anesthetics is one of 
the most likely causes of PONV, consistent with our find-
ings from all patients included in the meta-analysis. The 
type of surgery is also strongly believed to be a risk factor 
for PONV,17 and recent studies suggest laparoscopic and 
gynecologic surgery and cholecystectomy are independent 
risk factors for PONV.21–23 During laparoscopic surgery, 
CO
2
 pneumoperitoneum stimulates mechanoreceptors in the 
gastrointestinal tract, which leads to the release of serotonin 
and other neurotransmitters and increases the incidence 
of PONV.
Notably, the effect of perioperative dextrose on PONV 
varied according to the type of surgery. Here, perioperative 
dextrose effectively reduced the risk for PONV in three stud-
ies of laparoscopic cholecystectomy but not in four studies of 
other types of surgery. We cannot clearly explain this result, 
although as noted, i.v. dextrose might improve the risk for 
PONV via a mechanism related to hyperglycemia. In a pre-
vious study, the pH of gastric juice decreased significantly 
during laparoscopic cholecystectomy,24 and this phenomenon 
might induce gastric contraction.25 Hyperglycemia can reduce 
gastric acid secretion by inhibiting the vagal cholinergic 
pathways,7,8 and a recent previous study identified chole-
cystectomy as a cause of the severe duodenogastric reflux 
Figure 2 Risk of bias of original studies.
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Figure 3 Forest plot of the effects of perioperative intravenous dextrose administration on the risk for postoperative nausea and vomiting according to the type of 
surgery.
strongly associated with early gastric mucosal changes.26 
The high osmotic pressure induced by i.v. dextrose also can 
reduce gastrointestinal wall contractions.11 Increased blood 
glucose levels may also increase the plasma level of chole-
cystokinin, a gastrointestinal peptide hormone that modulates 
anxiety and pain via its functions within the brain and conse-
quently reduces pain and PONV.27 Although cholecystokinin 
levels have not been evaluated during cholecystectomy, 
altered concentrations of this hormone have been detected 
in patients after cholecystectomy.28
Furthermore, the effects of dextrose on the risk for PONV did 
not differ according to the administered fluid volume. However, 
the postoperative glucose levels were higher in the dextrose group 
relative to the control group, which may explain the reduced 
need for anti-emetics in the former group. In the four studies 
reporting postoperative glucose levels, however, the glucose 
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Figure 4 Forest plot of the effects of perioperative intravenous dextrose administration on the risk for postoperative vomiting according to the type of surgery.
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Figure 5 Forest plot of the effects of perioperative intravenous dextrose administration on the requirement for anti-emetic therapy according to the type of surgery.
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Figure 6 Forest plot of the effect of perioperative intravenous dextrose administration on the risk for postoperative nausea and vomiting stratified by the volume of dextrose fluid.
levels also differed between the control groups. Perioperative 
dextrose was found to be effective at postoperative glucose 
levels ,100 mg dL-1, suggesting that hypoglycemia prevention 
might be more important than an elevated glucose level.
The present meta-analysis had some limitations that 
should be considered when interpreting the results. We 
included studies that varied with respect to the type of 
surgery and volume of administered dextrose fluid, which 
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Figure 7 Forest plot of the effects of perioperative intravenous dextrose administration on postoperative glucose levels (mg dl-1).
'H[WURVH &RQWURO 0HDQGLIIHUHQFH,9UDQGRP&O
/RZOHYHOGH[WURVH
+HWHURJHQHLW\τ χ GI 3, 7HVWIRURYHUDOOHIIHFW= 3  /RZOHYHOFRQWURO± ± 
0HDQ

0HDQGLIIHUHQFH,9UDQGRP&O
±±±
±
±
:HLJKW



7RWDO


7RWDO


0HDQ

6WXG\RUVXEJURXS
$WDVKNKRHL6)LURX]LDQ$3DWHO3
7RWDO&O
5DR9

6'


6'

may account for some of the heterogeneity observed in our 
analytical results. We could reduce heterogeneity in the 
subgroup analysis of studies only involving laparoscopic 
cholecystectomy. However, further studies are needed in 
this subgroup in that the incidence of PONV was reported 
only in two studies. Second, because the studies included 
in this meta-analysis were mostly limited to laparoscopic 
cholecystectomy and gynecologic surgeries, the results of 
this meta-analysis cannot be generalized to other surgeries. 
Further studies with larger numbers of patients and more var-
ied types of surgeries are warranted to clarify the beneficial 
effects of perioperative i.v. dextrose on PONV in patients 
under general anesthesia.
Conclusion
Perioperative i.v. dextrose did not reduce the incidence of 
PONV but did reduce the need for anti-emetics after general 
anesthesia. However, dextrose did reduce the incidence 
of PONV among patients who underwent laparoscopic 
cholecystectomy. More studies are needed to determine the 
benefit of perioperative dextrose as a preventive measure 
against PONV.
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